NCI Designated Cancer Center
As Georgia’s first and only National Cancer Institute-designated cancer center, Winship Cancer Institute is a national leader in seeking out new ways to defeat cancer and in translating that knowledge into patient care. With over 250 active Phase I, II, and III clinical trials, Winship researchers are dedicated to taking new cancer treatments from bench to bedside.Learn About Our NCI Designation
Recognized for Nursing Excellence
Emory University Hospital and Emory Saint Joseph's Hospital, two of Winship’s clinical sites have achieved the prestigious Magnet® recognition as a reflection of its nursing professionalism, teamwork and quality in patient care. Magnet recognition is granted by the American Nurses Credentialing Center's (ANCC) Magnet Recognition Program®, which ensures that rigorous standards for nursing excellence are met.Learn About Our Patient Care
#1 in Georgia for Cancer Care
Winship Cancer Institute is part of Emory Healthcare, Georgia’s largest health care system. Our world-class physicians have a wealth of experience in hematology and medical oncology, radiation oncology, surgical oncology and pathology. Our nurses, navigators, social workers, technicians and others are all part of the comprehensive cancer care team.Visit Emory Healthcare
"Every doctor and nurse I met was just so caring, patient and encouraging. They were everything I needed them to be."
"It meant everything to me, just knowing about all the love and support. I want to find a cure. Not only just for me, but for everybody else."
"Dr. Lonial keeps pulling rabbits out of his hat for another treatment, another clinical trial. Things are good!"
"Winship doesn't just treat the disease, they treat the heart, the mind and the soul."
- Feb. 5, 2016
Puri Memorial Lecture kicks off at Winship
The inaugural Surinder K. Puri Memorial Lecture was held today at Winship Cancer Institute of Emory University with invited guest speaker, Ash A. Alizadeh, MD, PhD, of Stanford Medicine presenting "Personalized Cancer Detection and Monitoring Using Deep Sequencing of Circulating Tumor DNA".